Safety and effectiveness of monovalent COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden

Real-world evidence on the safety and effectiveness of Coronavirus Disease 2019 (COVID-19) vaccination against severe disease caused by the omicron variant among adolescents is sparse. In addition, evidence on risk factors for severe COVID-19 disease, and whether vaccination is similarly effective i...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	PLoS medicine Ročník 20; číslo 2; s. e1004127
Hlavní autoři:	Nordström, Peter, Ballin, Marcel, Nordström, Anna
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Public Library of Science 21.02.2023 Public Library of Science (PLoS)
Témata:	Adolescent Adolescents Bacterial infections Biology and Life Sciences Cohort analysis Cohort Studies Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 vaccines Developmental disabilities Drug therapy Hospital care Hospitalization Humans Immunization Infections Influenza Medicine and Health Sciences Messenger RNA mRNA mRNA vaccines Observational studies Paralysis People and places Public health Regression analysis Risk Factors Risk groups RNA, Messenger Safety Safety and security measures SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Statistics Sweden - epidemiology Teenagers Tonsillitis Vaccination Vaccine efficacy Youth Sweden United States > US
ISSN:	1549-1676, 1549-1277, 1549-1676
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!